132 related articles for article (PubMed ID: 34244176)
1. Operations management on the front line of COVID-19 vaccination: building capability at scale via technology-enhanced learning.
Smith IM; Bayliss E; Salisbury H; Wheeler A
BMJ Open Qual; 2021 Jul; 10(3):. PubMed ID: 34244176
[TBL] [Abstract][Full Text] [Related]
2. Mass production methods for mass vaccination: improving flow and operational performance in a COVID-19 mass vaccination centre using Lean.
Smith IM; Smith DTL
BMJ Open Qual; 2021 Sep; 10(3):. PubMed ID: 34518300
[TBL] [Abstract][Full Text] [Related]
3. Application of the "immunization islands" model to improve quality, efficiency and safety of a COVID-19 mass vaccination site.
Signorelli C; Odone A; Gianfredi V; Capraro M; Kacerik E; Chiecca G; Scardoni A; Minerva M; Mantecca R; Musarò P; Brazzoli P; Basteri P; Bertini B; Esposti F; Ferri C; Alberti VA; Gastaldi G
Ann Ig; 2021; 33(5):499-512. PubMed ID: 34113956
[TBL] [Abstract][Full Text] [Related]
4. Validation Checklist for Massive Vaccination Centers.
Capolongo S; Brambilla A; Girardi A; Signorelli C
Ann Ig; 2021; 33(5):513-517. PubMed ID: 34224553
[TBL] [Abstract][Full Text] [Related]
5. Key populations for early COVID-19 immunization: preliminary guidance for policy.
Ismail SJ; Zhao L; Tunis MC; Deeks SL; Quach C;
CMAJ; 2020 Nov; 192(48):E1620-E1632. PubMed ID: 33144317
[No Abstract] [Full Text] [Related]
6. Covid-19 vaccine roll-out in England: A qualitative evaluation.
Mounier-Jack S; Paterson P; Bell S; Letley L; Kasstan B; Chantler T
PLoS One; 2023; 18(6):e0286529. PubMed ID: 37267295
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 and changes in the National Immunisation Program: a unique opportunity to optimise the Australian Immunisation Register (AIR).
Tuckerman J; Blyth CC; Beard FH; Danchin MH
Med J Aust; 2021 Apr; 214(6):247-249.e1. PubMed ID: 33745151
[No Abstract] [Full Text] [Related]
8. Seeking to address issues with COVID-19 vaccines in Japan and to resolve global problems with vaccination programmes.
Inoue K; Ohira Y; Kawano N; Takeshita H; Hashioka S
Int Marit Health; 2021; 72(2):142. PubMed ID: 34212355
[No Abstract] [Full Text] [Related]
9. Lessons from the United Kingdom's COVID-19 vaccination strategy.
Harnden A; Earnshaw A
Med J Aust; 2021 May; 214(9):417-419. PubMed ID: 33893643
[No Abstract] [Full Text] [Related]
10. Encouraging covid vaccine uptake and safe behaviours-an uphill struggle against government complacency.
Patterson L
BMJ; 2021 Nov; 375():n2773. PubMed ID: 34772667
[No Abstract] [Full Text] [Related]
11. Key steps in our journey to a COVID-19 vaccine program.
Blyth CC; Flanagan KL; Gibbs RA; Crawford NW; Cheng AC
Med J Aust; 2021 Apr; 214(6):249-251.e1. PubMed ID: 33745153
[No Abstract] [Full Text] [Related]
12. Randomized COVID-19 vaccination rollout can offer direct real-world evidence.
Hemkens LG; Goodman SN
J Clin Epidemiol; 2021 Oct; 138():199-202. PubMed ID: 34048910
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 Vaccine Distribution and Allocation: What Physicians Need to Know.
Laine C; Cotton D; Moyer DV
Ann Intern Med; 2021 Mar; 174(3):413-414. PubMed ID: 33492990
[TBL] [Abstract][Full Text] [Related]
14. Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients.
Amit S; Regev-Yochay G; Afek A; Kreiss Y; Leshem E
Lancet; 2021 Mar; 397(10277):875-877. PubMed ID: 33610193
[No Abstract] [Full Text] [Related]
15. Venezuela is collapsing without COVID-19 vaccines.
Loyo ESL; González MJ; Esparza J
Lancet; 2021 May; 397(10287):1806. PubMed ID: 33992140
[No Abstract] [Full Text] [Related]
16. Joining forces to administer COVID-19 vaccines.
Johnson KH
J Osteopath Med; 2021 Mar; 121(4):429-430. PubMed ID: 33694357
[TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 vaccines for all but a single dose for COVID-19 survivors.
Frieman M; Harris AD; Herati RS; Krammer F; Mantovani A; Rescigno M; Sajadi MM; Simon V
EBioMedicine; 2021 Jun; 68():103401. PubMed ID: 34051441
[No Abstract] [Full Text] [Related]
18. The Century of mRNA Vaccines: COVID-19 Vaccines and Allergy.
Ortega Rodríguez NR; Audícana Berasategui MT; de la Hoz Caballer B; Valero Santiago A
J Investig Allergol Clin Immunol; 2021 Feb; 31(1):89-91. PubMed ID: 33393485
[No Abstract] [Full Text] [Related]
19. Experts Discuss COVID-19: Vaccine Allocation, Placebo Groups, and More.
JAMA; 2020 Dec; 324(23):2354-2355. PubMed ID: 33320222
[No Abstract] [Full Text] [Related]
20. COVID-19 Vaccine Development to Vaccination.
Pandey A; Belbase P; Parajuli A
J Nepal Health Res Counc; 2021 Jan; 18(4):807-809. PubMed ID: 33510536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
